Hinova Pharmaceuticals, Inc.SSE: 688302

Announcement on Preliminary Earnings Estimate for 2024

Feb 28, 2025 · Issued by Hinova Pharmaceuticals, Inc. via Shanghai Stock Exchange

Filed with SSE · Feb 28, 2025

On 6ix: 6ix.com/news/announcement-on-preliminary-earnings-estimate-for-2024-304

Announcement on Preliminary Earnings Estimate for 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Hinova Pharmaceuticals, Inc. on 6ix

Earlier from Hinova Pharmaceuticals

Announcement on Voluntary Disclosure of Completing First Subject Enrollment for Clinical Trial of HP515 Tablets in ChinaJan 20, 2025
Annual Earnings Preannouncement for 2024Jan 18, 2025
Announcement on Voluntary Disclosure of Completing First Subject Enrollment for Clinical Trial of Oral PROTAC Drug HP568 Tablets in ChinaJan 10, 2025
Announcement on Extension of Some Investment Projects Financed by Raised Funds from Initial Public Offering of SharesJan 4, 2025
Voluntary Disclosure on of Obtaining FDA Approval for Clinical Trial Application of Oral PROTAC Drug HP568 Tablets in the Treatment of ER+/HER2- Advanced Breast CancerDec 31, 2024

Later from Hinova Pharmaceuticals

Indicative Announcement on Change in Equity of Shareholders Holding More than 5% of SharesMar 6, 2025
Announcement on the Expiry of Planned Time for Shareholders with Over 5% Shares to Reduce Shares and Results of Share ReductionMar 26, 2025
Announcement on Listing and Circulation of Partial Restricted Stocks in Initial Public OfferingApr 4, 2025
Announcement on Resolution of the 8th Meeting of the 2nd Board of SupervisorsApr 19, 2025
Announcement on Application for Mortgage Loan from BankApr 26, 2025

All Hinova Pharmaceuticals news releases

Follow Hinova Pharmaceuticals into a list and get an email when it puts out news.

Follow Hinova Pharmaceuticals